Combihale FF 250 mcg Redicaps (30 Cap)

About Combihale FF 250 mcg Redicaps:

Combihale FF 250 mcg Redicap is used in the treatment of asthma and chronic obstructive pulmonary disorder (COPD).

Each Combihale FF 250 mcg Redicap Capsule contains Formoterol Fumarate Dihydrate equivalent to Formoterol Fumarate 6 mcg and Fluticasone Propionate 250 mcg.

Fluticasone propionate is a synthetic, trifluorinated glucocorticoid with potent anti-inflammatory activity. It exerts its beneficial effects by inhibiting several types of cells and mediators involved in allergic, immune, and inflammatory responses.

Formoterol is a very potent long-acting adrenoceptor beta2-agonist with high intrinsic activity and rapid onset of action. Formoterol stimulates the beta -2 receptor, causing bronchodilation by relaxing the smooth muscle in the airway.

Use of Combihale FF 250 mcg Redicaps:

Combihale FF 250 mcg Redicap is prescribed for the management of asthma and chronic obstructive pulmonary disorder (COPD).

Usage direction of Combihale FF 250 mcg Redicaps:

• Combihale FF 250 mcg Redicaps are intended for oral inhalation use only.
• Capsules are intended for use with Redihaler Device only and are not to be swallowed.
• After taking this medicine, rinse your mouth with water and split out.
• Physician will advise the right dose and duration as per the patient’s condition.
• Before using Combihale FF 250 mcg Redicap, know the administration process properly from enclosed leaflet.
• Always keep the container tightly closed.
• Do not exceed the recommended dose.

Precaution & Related information of Combihale FF 250 mcg Redicaps:

• If allergic to Combihale FF 250 mcg Redicaps, inform the physician immediately.
• If find any other complication inform the physician immediately.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.

Storage condition of Combihale FF 250 mcg Redicaps:

Store protected from moisture, at a temperature not exceeding 30°C.